SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending amidst fervent community debate over its immediate direction, with bulls pointing to strong on-chain activity, like surging daily transactions and declining gas fees, alongside bullish chart patterns signaling a potential breakout. However, bearish sentiment persists, fueled by broader market volatility and uncertainty surrounding the delayed Digital Asset Market Clarity Act and recent geopolitical tariff discussions. The intense back-and-forth reflects a market seeking conviction on whether the current price action represents a healthy pullback or a precursor to further declines.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as discussions intensify around former President Trump's proposed tariffs on European nations in connection with Greenland, leading to widespread concern about potential global trade disputes. The community is sharply divided, with supporters viewing these actions as strategic moves to secure national interests, while critics fear significant negative impacts on the economy and international relations.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPDR S&P 500 ETF Trust (SPY) is trending as investors grapple with escalating geopolitical tensions stemming from recent tariff threats against Europe concerning Greenland. While some predict a significant market downturn, citing red futures and potential economic disruption, others anticipate a quick recovery, referencing past instances where such threats were walked back. The community is actively debating the market's direction, with discussions highlighting both caution and the expectation of a 'buy the dip' opportunity after the extended holiday.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amidst escalating global trade tensions, driven by new US tariff threats against European nations regarding Greenland and reports of potential EU retaliatory measures. Community discussions are sharply divided between anticipating a significant market pullback for the tech-heavy Nasdaq and a belief that historical "buy the dip" patterns will prevail, especially with a Supreme Court ruling on tariffs keenly awaited.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending amid intense community discussion focused on global trade tensions, including renewed tariff talks, and broader market uncertainty driving recent volatility. Many users are debating whether this presents a "buy the dip" opportunity while others express concern over perceived market manipulation and Bitcoin's challenged "safe haven" narrative.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash (BCH) is actively trending as the community highlights its recent outperformance and resilience, appearing to decouple from broader crypto market movements. This momentum is further fueled by news of its integration-ready post-quantum vault upgrade and persistent rumors of substantial institutional buying interest, leading many to anticipate a significant price breakout.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix ($OCUL) is actively trending on reports that Sanofi ($SNY) is preparing an increased takeover offer, following the rejection of an initial $16 per share bid by OCUL's board. This, alongside Ocular's strategic decision to pursue an accelerated FDA submission pathway for its wet AMD drug AXPAXLI based on upcoming Phase 3 data, is driving strong community conviction in a much higher valuation and potential bidding war among major pharmaceutical companies.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is surging following an impressive financial report that exceeded expectations and a substantial dividend increase, signaling a robust rebound in investment banking and capital markets activity. This performance is fueling broad bullish sentiment across the financial sector, though some community discussions reflect skepticism and accusations of market manipulation related to a controversial downgrade of another trending stock.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending after a recent analyst upgrade to "Buy," signaling strong confidence in its robust oncology pipeline and anticipated clinical trial data for cancer therapies. While the market highlights its strategic pivot and solid financial position as key growth drivers, a vocal segment of the community remains highly focused on skepticism surrounding mRNA technology, echoing past controversies related to its COVID-19 vaccines.

BlackRock Institutional Trust Company N.A. - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is trending strongly as robust demand for AI chips from leading companies like TSMC, Micron, and AMD fuels significant market optimism. Investors are actively discussing the sector's pivotal role in the AI revolution, with many advocating to "buy the dip" while others express caution regarding potential market overextension. Geopolitical considerations, including US-Taiwan chip collaborations and China's domestic semiconductor strategy, also remain key talking points shaping the broader industry outlook.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cogent Biosciences (NASDAQ:COGT) Shares Up 7.1% - Still a Buy?

Cogent Biosciences (NASDAQ:COGT) Stock Price Up 7.1% - Still a Buy...

Voya Investment Management LLC Increases Stock Position in Cogent Biosciences, Inc. $COGT

Voya Investment Management LLC increased its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 110.0% during the 3rd quarter, according to its most recent filing with the...

Best Biotech Stocks To Follow Today - December 31st

Abivax, Danaher, and Cogent Biosciences are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop and...

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down Following Insider Selling

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down Following Insider Selling...

Evan Kearns Sells 65,000 Shares of Cogent Biosciences (NASDAQ:COGT) Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Evan Kearns sold 65,000 shares of the company's stock in a transaction dated Friday, December 26th. The shares were sold at an average...

Insider Selling: Cogent Biosciences (NASDAQ:COGT) Insider Sells 65,000 Shares of Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Evan Kearns sold 65,000 shares of the company's stock in a transaction dated Friday, December 26th. The stock was sold at an average...

Cogent Biosciences (NASDAQ:COGT) Insider John Edward Robinson Sells 90,000 Shares

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider John Edward Robinson sold 90,000 shares of the company's stock in a transaction dated Friday, December 26th. The stock was sold at an...

Cogent Biosciences (NASDAQ:COGT) Insider Sells $3,198,245.40 in Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Jessica Sachs sold 82,642 shares of the company's stock in a transaction on Friday, December 26th. The stock was sold at an average...

Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen analysts that are covering the firm, Marketbeat Ratings reports. One...

Squarepoint Ops LLC Purchases Shares of 101,518 Cogent Biosciences, Inc. $COGT

Squarepoint Ops LLC acquired a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the...

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

COGT
Cogent Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COGT News

COGTCogent Biosciences Inc